FDA Modernization Act 2.0: Accelerate Readiness with an Advanced LIMS Solution
In April 2025, clinical research reached a turning point, with advances reshaping both the science and the regulations that guide it. The FDA unveiled its Roadmap to Reducing Animal Testing in Preclinical Safety Studies, offering a phased strategy for integrating non-animal methods into drug development. Around the same time, the NIH announced the launch of ORIVA—the Office of Research Innovation, Validation, and Application—dedicated to scaling up human-relevant research models. These parallel initiatives highlight a growing consensus: animal models are too often poor predictors of human outcomes, and new technologies can provide safer, faster, and more ethical alternatives.
